Type 2 Diabetes

>

Latest News

Novo Nordisk | Credit: Novo Nordisk
Monlunabant Misses Primary Endpoint in Phase 2 Diabetic Kidney Disease Trial

February 5th 2025

Completion of the trial was announced in a financial update from Novo Nordisk, who explained the trial missed its primary endpoint for uACR improvement.

Kasia Lipska, MD, MHS, associate professor of medicine
Investigating the Link Between Type 2 Diabetes and Infection

February 4th 2025

Endocrinology Month in Review: January 2025 | Image Credit: HCPLive
Endocrinology Month in Review: January 2025

February 4th 2025

The HCPFive: Top News for Healthcare Providers from the Week of 1/26
The HCPFive: Top News for Healthcare Providers from the Week of 1/26

February 1st 2025

FDA News Month in Review: January 2025 | Image Credit: HCPLive
FDA News Month in Review: January 2025

January 31st 2025

Video Series
Video Interviews
Podcasts
Medical Ethics Unpacked: GLP-1 Allocation
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics| Image Credit: HCPLive
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas | Image Credit: HCPLive
Diabetes Dialogue: Insights on INHALE-1 and CATALYST Trials | Image Credit: HCPLive
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Irl Hirsch, MD | Credit: University of Washington
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive

More News

© 2025 MJH Life Sciences

All rights reserved.